Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0000899243-20-030410

Director bought 66,666 shares at $15.00 ($999,990)

  • Director acquired 479,470 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Christgau Stephan Director 2020-11-02 Conversion +479,470 479,470 I
Christgau Stephan Director 2020-11-02 Purchase +66,666 $15.00 $999,990 546,136 I
Derivatives
Christgau Stephan Director 2020-11-02 Conversion · Series D Preferred Stock −184,433 0 I
Open-market purchases · 66,666 sh · avg $15.00 · $999,990
Loading xslF345X03/doc4.xml…